Van Andel Institute Unveils Epigenetics Research Hub | GenomeWeb

NEW YORK (GenomeWeb News) – The Van Andel Institute plans to become a hub of epigenetics research by developing a consortium of four US academic institutions and one from abroad that will collaborate to develop new personalized epigenetic treatments.

The initiative will be led by Peter Jones, director of research and chief scientific officer at the Van Andel Research Institute, which is based at VAI's headquarters in Grand Rapids, Mich. He already is working with international research partners on epigenetic therapies to treat cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.